迪哲医药股价涨5.2%，同泰基金旗下1只基金重仓，持有3.76万股浮盈赚取12.42万元

Group 1 - The core point of the news is that Dize Pharmaceutical has seen a stock price increase of 5.2%, reaching 66.75 yuan per share, with a total market capitalization of 30.784 billion yuan [1] - Dize Pharmaceutical, established on October 27, 2017, focuses on the research and industrialization of innovative drugs, with 100% of its main business revenue coming from drug sales [1] - The company is located in Wuxi, Jiangsu Province, and has been listed since December 10, 2021 [1] Group 2 - According to data, the Tongtai Health Theme Mixed A Fund (011002) holds 37,600 shares of Dize Pharmaceutical, accounting for 5.41% of the fund's net value, making it the fifth-largest holding [2] - The fund has a total scale of 13.7512 million yuan and has achieved a year-to-date return of 7.74%, ranking 577 out of 8,827 in its category [2] - The fund's one-year return is 25.89%, with a ranking of 4,600 out of 8,084, while it has experienced a cumulative loss of 50.98% since inception [2] Group 3 - The fund managers of Tongtai Health Theme Mixed A are Ma Yi and Mai Jianpei, with Ma Yi having a tenure of 11 years and 299 days and a total fund size of 2.718 billion yuan [3] - During Ma Yi's tenure, the best fund return was 44.72%, while the worst was -7.73% [3] - Mai Jianpei has a tenure of 243 days with a fund size of 231 million yuan, achieving a best return of 23.27% and a worst return of -7.73% during his tenure [3]